Institute for Pharmaceutical Biology, University of Bonn , Nussallee 6, D-53115 Bonn, Germany.
J Nat Prod. 2014 Jan 24;77(1):159-63. doi: 10.1021/np400740u. Epub 2014 Jan 14.
The myxobacterium Corallococcus coralloides is the producer of the antibiotic compound corallopyronin A, which is currently in preclinical evaluation. To obtain suitable amounts of this antibiotic, the production strain C. coralloides B035 was cultured in large volumes, which in the addition to the isolation of the target molecule facilitates the detection of additional metabolites of this myxobacterial strain (corallorazines A-C). Corallorazine A is a new structural type of dipeptide composed of a dehydroalanine and a glycine moiety that are linked via a semiaminal bond, thus forming a piperazine ring. The latter is further connected via an amide bond to an unusual aliphatic acyl chain.
粘球菌科珊瑚球菌属的粘细菌珊瑚球菌 B035 是抗生素化合物珊瑚磷酮 A 的产生菌,目前正处于临床前评估阶段。为了获得足够数量的这种抗生素,需要大量培养生产菌株 C. coralloides B035,这不仅有利于目标分子的分离,还有助于检测这种粘细菌菌株的其他代谢产物(corallorazines A-C)。珊瑚洛嗪 A 是一种新型二肽结构类型,由一个脱氢丙氨酸和一个甘氨酸部分通过半亚胺键连接,从而形成一个哌嗪环。后者通过酰胺键进一步与一个不寻常的脂肪酰链连接。